Who is sponsoring NCT05811611?

NCT05811611 is sponsored by Chinese University of Hong Kong.

What condition does NCT05811611 study?

NCT05811611 studies Behavior, Sex.

Is NCT05811611 still recruiting?

NCT05811611 is currently status unknown. Last updated 13 April 2023.

Last reviewed 2023-04-13 · How we verify

NCT05811611

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Two WeChat Mini Program-based Interventions Reducing Sexual Risk Behaviors Among Heterosexual Male Factory Workers

Status unknown NA Last updated 13 April 2023

What this trial tests

NA trial testing WeChat Mini Program plus tailored online health promotion videos in Behavior, Sex in 244 participants. Status unknown.

Timeline

1 December 2021

Primary endpoint
30 April 2023

30 April 2023

Quick facts

Lead sponsor	Chinese University of Hong Kong
Phase	NA
Status	Status unknown
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	single
Primary purpose	prevention
Enrollment	244
Start date	1 December 2021
Primary completion	30 April 2023
Estimated completion	30 April 2023
Sites	1 location across Hong Kong

Drugs / interventions tested

WeChat Mini Program plus tailored online health promotion videos
WeChat Mini Program Only

Conditions studied

Behavior, Sex — all drugs for Behavior, Sex →

Sponsor

Chinese University of Hong Kong

Who can join

18 and older, male only, with Behavior, Sex. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

A non-blinded parallel group randomized controlled trial is conducted. Adult male full-time employees of factories in Shenzhen who have access to smartphone and WeChat are recruited by staff of the Longhua Center for Disease Control and Prevention (CDC). After completing an online baseline questionnaire, participants will be randomized evenly to either the intervention group or the control group. Participants in the control group will have access to a WeChat Mini Program providing HIV and sexually transmitted prevention information during the project period. In addition to those received by the control group, the Mini Program will proactively ask participants in the intervention group some simple questions to assess presence of sexual risk behaviors at Month 0 and Month 1, and invite them to watch online health promotion video(s) tailored to their current sexual risk behaviors. All participants will complete two online follow-up surveys six and twelve months after completion of the interventions.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Comparing the Efficacy of 2 WeChat Mini Programs in Reducing Nonmarital Heterosexual Contact by Male Factory Workers: Randomized Controlled Trial.
Zhang K, Cao B, Fang Y, Liang X, et al · · 2024 · cited 3× · PMID 39250213 · DOI 10.2196/49362

Verify or expand the search:

Other Chinese University of Hong Kong trials

Trials by the same sponsor.

NCT07508644 — RSV Vaccination to Reduce Recurrent AECOPD · Phase 4 · not yet recruiting
NCT07230457 — Plasma MTB cfDNA Before Bronchoscopy · not yet recruiting
NCT07288671 — Nostalgia Intervention on Alleviating Loneliness Amongst Older Adults · NA · not yet recruiting
NCT07256457 — Postoperative Pulmonary Function Assessment Based on Deep Learning Study · NA · not yet recruiting
NCT06904209 — Can Artificial Intelligence Reduce Consumption of Standard High Volume Bowel Preparation Regimen Among Older Population, · NA · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05811611 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Chinese University of Hong Kong
Last refreshed: 13 April 2023

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05811611.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing